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In investigating the feedback effects of circulating hormones on the brain, we showed previously that adrenalectomy (ADX) increases vasoactive intestinal peptide (VIP)-stimulated CAMP generation in slices from rat hippocampus, a brain structure with high levels of glucocorticoid receptors. This effect is reversed by replacement with glucocorticoids such as dexamethasone (DEX) and corticosterone (CORT). Here we report that, like ADX, hypophysectomy (HYPOX) also elevates VIP-stimulated CAMP generation, compared with sham-operated controls.
Moreover, like glucocorticoid replacement, administration of ACTH to HYPOX rats causes a decrease in CAMP stimulation by VIP. Furthermore, ACTH had no effect when given to HYPOX+ADX rats, indicating that the effects of ACTH require the presence of adrenal steroid secretion.
However, we find that ACTH may have a permissive role in this glucocorticoid effect because, in the absence of the pituitary, DEX treatment does not decrease VIP-stimulated CAMP levels in the hippocampus.
In addition, hippocampal @-adrenergic-stimulated CAMP accumulation was not suppressed by DEX treatment of HYPOX rats, which again is different from the effect of DEX treatment on ADX animals. These results are discussed in terms of possible synergism between pituitary hormones and steroid hormones in exerting feedback actions on brain function.
The nervous system controls the endocrine response to stressful stimuli and is also a target for the actions of adrenal steroids and ACTH secreted in stress . The feedback actions of adrenal steroids are mediated, at least in part, via intracellular receptors and lead to neurochemical and structural alterations in the nervous system (McEwen, 1982; McEwen et al., 1986; Sapolsky et al., 1986) . We have shown previously that in vivo glucocorticoid treatment influences the ability of several putative neurotransmitters to stimulate CAMP accumulation in slices from rat hippocampus , a brain region containing high levels of specific receptors for glucocorticoids (McEwen et al., 1968; Gerlach and McEwen, 1972; Sapolsky et al., 1983) . Since these effects occurred only when glucocorticoid levels were manipulated in vivo, it is possible that this steroid action on the hippocampus might be mediated by other hormones, e.g., by pituitary hormones such as ACTH, which is regulated by glucocorticoids. A number of investigators have reported that pituitary hor-mones, including ACTH, can alter the function of the CNS, including effects on memory, electrophysiology, and neurochemistry (Pfaff et al., 197 1; Urban and de Weid, 1976; Kendall et al., 1982; Olpe and Jones, 1982; Veldhuis and de Kloet, 1982; Markey and Sze, 1984) . In order to test the hypothesis that our previous results might involve the action of pituitary hormones such as ACTH on the nervous system, we measured neurotransmitter-stimulated CAMP accumulation in hippocampal slices from hypophysectomized (HYPOX) rats that had been treated in various ways. Our results suggest that glucocorticoids act directly on the brain to cause changes in CAMP synthesis but that ACTH may have a permissive role in this steroid action.
Materials and Methods
Materials. ACTH was obtained as Acthar Gel from Armour Pharmaceuticals. Purified porcine VIP was obtained from Dr. Viktor Mutt (Stockholm). Rolinram (ZK 62.7 11) was a gift from Scherina AG (Berlin). Pellets'of 25% dexamethasone'(DEX)were prepared according to Meyer et al. (1979) . Average implant weight was 145 mg.
Animals, surgery, and steroid treatment. HYPOX male rats were purchased from Charles River Breeding Co. and delivered 7 d after surgery. The rats were 8-12 weeks old at the beginning of each experiment and weighed approximately 180-240 gm. The animals were housed on a 14: 10 light : dark schedule with lights on at 5 a.m. Food (Purina Lab Chow for rats) and water were available ad libitum. HYPOX rats were maintained on 5% dextrose until being sacrificed 2-3 weeks later. Where indicated. HYPOX rats were iniected with 8 units/d ACTH. Adrenalectomies '(ADX) were bilateral-via a dorsal approach. Animals were tested 3 d after ADX. In sham-operated animals, incisions were made in the body wall and the adrenals were sighted but not removed. ADX rats were given 0.9% NaCl in drinking water to maintain salt balance.
Slice preparation, stimulation, and CAMP measurement. Rats were killed by decapitation. The brains were rapidly removed and dissected on ice (Rotsztejn et al., 1980) . Each dissected hippocampus was sliced on a McIlwain tissue chopper twice at right angles at a thickness of 0.325 mm. Sliced hippocampal tissue was immediately transferred to Erlenmeyer flasks filled with oxygenated Krebs-Ringer buffer (concentrations in mM: NaCl, 124; KCl;5.00; NaHC03, 26.0; CaCl;, 0.800; M&l,. 1.30: KI-LPO,. 1.40: dextrose. 10.0. nH 7.4). The volume of b&er&'was adjusted to give a wet-weight : volume ratio of 1: 100. The slices were rinsed with buffer once, and the flasks were then flushed with oxygen, capped, and placed in a shaking water bath at 37°C at a moderate shaking speed (150 rotations/min). The preincubation period lasted for 60 min; each flask was flushed with 95% oxygen/5% carbon dioxide every 10 min, and the medium was aspirated and replaced with an equal volume of fresh Krebs-Ringer medium at 20 and 40 min. For the last 40 min of preincubation, the medium contained 30 PM Rolipram (ZK 62,7 1 l), a phosphodiesterase inhibitor (Schwabe, 1976) .
At the end of the preincubation period, slices were pipetted from the Erlenmeyer flasks into 1.5 ml plastic minivials, 450 ~1 each. The vials were then flushed with oxygen and tightly capped and placed into horizontal carriers in the shaking water bath. After 10 min, the vials were removed from the bath and 50 ~1 of neurotransmitter stock solution was added; the vials were once again flushed with oxygen, capped tightly, and placed back into the shaking water bath. Twelve minutes later they were removed, the medium quickly aspirated from the slices, and 250 ~1 of ice-cold 7% trichloroacetic acid (TCA) added to each tube. The CAMP generation is linear with time up to 20 min and with protein amount (data not shown).
The TCA-treated slices were sonified and then centrifuged for 10 min in a Beckman microfuge at 10,000 x g. The pellets were resuspended in 250 11 of 0.2 N NaOH by sonification and assayed for protein by the procedure of Bradford (1976) . The TCA supematants (250 ~1) were extracted 3 times with 6 volumes of diethyl ether and placed in a 37°C water bath to evaporate any remaining traces of ether. After 90 min the supematants were removed from the water bath, and 10 ~1 of pH 7.4 Tris (750 mM) was added to each, to neutralize any leftover TCA and correct the pH. Aliquots of supematant were then taken for CAMP assay by the method of Brown et al. (197 1) .
The results of all experiments were subjected to analyses of variance and where significant differences occurred were tested with the Student's t test for planned pair comparisons or with the Duncan's test for post hoc comparisons of multiple groups.
Results
Because DEX decreases VIP-stimulated CAMP accumulation in the hippocampus of ADX rats , we first tested the effects of DEX replacement on HYPOX animals, expecting that if glucocorticoids were acting directly on the CNS, then DEX would produce the same effect that occurs in ADX animals. Unexpectedly DEX did not reduce VIP stimulation in HYPOX animals; instead, there was a slight increase (Fig. 10) . We obtained the same paradoxical effect when we measured P-adrenergic stimulation of hippocampal CAMP accumulation in DEX-treated HYPOX rats (Table 1) . In this case, glucocorticoid replacement caused isoproterenol (ISOP)-and norepinephrine (NE)-stimulated CAMP levels to go up (Table l) , not down, as was the case in ADX animals (Roberts et al., 1984; .
These results imply that ACTH, or some other pituitary hormone, might be involved in the effects of DEX. However, if glucocorticoids have the predominant inlhtence on VIP-stimulated CAMP accumulation, then HYPOX, resulting in loss of anterior pituitary ACTH secretion, would abolish glucocorticoid secretion from the adrenal gland and produce an effect similar to ADX. That is exactly what occurred (Fig. 1A): i.e., 2 weeks after HYPOX, hippocampal VIP-stimulated CAMP generation was increased compared with sham-operated controls. Conversely, when we gave ACTH injections to HYPOX rats for 6 d and compared their hippocampal VIP stimulation of CAMP with that of vehicle-injected HYPOX controls, the ACTH treatment caused a reduction (Fig. 1B) . This is what would be expected if adrenal glucocorticoid stimulation brought about by ACTH was primarily responsible. It is nevertheless possible that regulation of the CAMP response to VIP was brought about, at least in part, by a direct action of the injected ACTH on the brain. We next determined whether the primary ACTH action was on the brain or on the adrenal gland by comparing the response to ACTH of HYPOX and HYPOX+ADX rats. As shown in Figure 1 C, the HYPOX rats without adrenals, and hence without the ability to secrete glucocorticoids in response to ACTH, do not respond to the ACTH treatment. Thus, the adrenal gland seems to be required for ACTH to act.
Discussion
Our results on VIP-stimulated CAMP generation in the hippocampus of HYPOX rats are summarized in Table 2 , along with the results of our previous studies on ADX animals . There is an inverse correlation between the changes in glucocorticoid levels and VIP stimulation in the hippocampus, i.e., when corticosterone (CORT) levels go down, CAMP generation goes up; and when CORT levels increase, CAMP accumulation goes down. In contrast, there is no correlation between expected ACTH levels and VIP-stimulated CAMP accumulation.
This implies that adrenal glucocorticoids, not ACTH, are the principal regulators of hippocampal CAMP accumulation and that these steroids act directly on the CNS, and not on the pituitary gland, to produce these effects. DEX appears to have the same effect as CORT, the natural glucocorticoid, as long as ACTH is present, and this is consistent with the involvement of the so-called Type 2 glucocorticoid receptor, which binds CORT as well as DEX .
There are cases in which the effects of drugs and nonsteroidal hormones on the CNS do not occur in HYPOX animals (Kikuyama et al., 1979; Heal et al., 1983) . For example, thyroid hormone has profound effects on brain development in a variety of species, and it has been found that the effects of this hormone on thyroid-deficient tadpoles are blocked by HYPOX (Kiku-yama et al. , 1979) . There are also instances in which the effects of HYPOX on CNS biochemistry are not reversed by DEX (Land0 and Raynaud, 1980; Markey and Sze, 1984) or are only partially reversed (Wong et al., 1982) . Moreover, ACTH or its metabolites can have effects independent of the adrenals, e.g., the ability of HYPOX to decrease GABA receptors in midbrain cannot be reversed by corticosterone administration, whereas replacement with a nonsteroidogenic ACTH fragment is effective in HYPOX rats (Kendall et al., 1982) . Apparently, in the present system, ACTH plays a permissive role in the glucocorticoid-induced changes involving VIP, in that ACTH must be present in some minimal quantity for the glucocorticoids to exert their suppressive effect on CAMP generating capacity (see further discussion below). Knowledge of how ACTH might act on the nervous system is limited. Peripheral injections of ACTH affect the hippocampus and other regions of the CNS. Pfaff et al. (197 1) found that i.v. administration of ACTH to rats caused significant changes in hippocampal unit activity. A similar result on the hippocampal EEG was found by Urban and de Wied (1976) . Furthermore, microiontophoretic application of ACTH to the locus coeruleus has excitatory effects, and peripheral injections of the noncorticotrophic fragment, ACTH(4-lo), facilitate receptor responses in the frontal cortex to antidepressant drugs and increase tyrosine hydroxylase activity in the locus coeruleus (Kendall et al., 1982; Olpe and Jones, 1982; Markey and Sze, 1984) .
There is little indication as to how circulating ACTH might get to the hippocampus since peripheral ACTH does not cross the blood-brain barrier in large amounts (Krieger and Liotta, 1979) , although it has been reported that blood-borne ACTH binds specifically to the median eminence-arcuate region of the rat hypothalamus (Van Houten et al., 198 1) . Alternatively, the action of ACTH might be mediated by the PNS. Recent studies on the sympathetic innervation of the rabbit pulmonary artery and the rat heart, as well as a-motoneurons in the frog, have discovered presynaptic ACTH receptors that, when activated, potentiate the release of neurotransmitters from these terminals (Bassett et al., 1978; Gothert, 1981 Gothert, , 1984 Johnstonet al., 1983) . Earlier investigations demonstrated that ACTH decreased transmitter release in rat phrenic nerve-diaphragm preparations (Birnberger et al., 1977) .
Whether by direct actions on the hippocampus or indirect action through other neural structures in the CNS or periphery, ACTH is required for the suppressive effects of glucocorticoids on VIP-stimulated CAMP accumulation. Moreover, ACTH appears to determine the direction of this glucocorticoid effect since in the absence of the pituitary, DEX tends to increase CAMP generating capacity, whereas in the presence of the pituitary, DEX decreases it. The positive effect of DEX has further possible biological significance in that female rats, with their pituitary glands in place, respond to DEX like HYPOX males by increasing CAMP generating capacity .
While the importance of this requirement for ACTH in the overall control of the stress response by the nervous system can only be a subject for speculation at this point, there is nevertheless growing interest in the question of synergism between pituitary and steroid hormones as a mechanism in hormone feedback on the brain. For example, in order for estradiol to decrease hypothalamic VIP content in female rats, high levels of serum prolactin are required, even though prolactin by itself has no effect (Maletti et al., 1982) . Moreover, in another instance where a steroid hormone alters a neurotransmitter-related event, it has recently been reported that an as-yet-unidentified pituitary factor is required for estradiol to decrease transcription of the gene for tyrosine hydroxylase in the rat hypothalamus (Blum et al., 1986 (Blum et al., , 1987 . In the absence of the pituitary, estradiol increases tyrosine hydroxylase gene transcription (Blum et al., 1986) . Similarly, the present study has shown that DEX treatment in the absence of circulating ACTH increases the CAMP generation elicited by VIP. In ADX rats, where ACTH is present, DEX treatment decreases VIP-stimulated CAMP synthesis . Thus, in both cases, the additional pituitary factor is a "switch" that changes the direction of the steroid effect. These examples are presently without a molecular explanation, but they serve to raise the possibility that interactions between steroid and pituitary hormones may occur frequently in the nervous system and contribute to the multifaceted endocrine influences on the brain that affect behavior as well as neuroendocrine output.
